Oct 17, 2019
IM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures
IM Therapeutics is a clinical stage company developing personalized therapies for autoimmune disease. On October 9th, they announced that...
Oct 16, 2019
Welcome IM Therapeutics to the C2I Family!
We would love to extend our warm welcome to IM Therapeutics! IM Therapeutics is redefining autoimmunity and transforming lives by...
Aug 29, 2019
C2I Accelerator has incubated over 26 portfolio companies!
At C2I Accelerator, we have successfully incubated over 26 portfolio companies including companies like SQZ Biotech, Frequency...
